A call for sharing individual patient data from trials in hepatology
Open Access
- 14 May 2026
- journal article
- review article
- Published by Elsevier in Journal of Hepatology
- Vol. 85 (3) , 630-635
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- FAIRification of biomedical research dataJournal of Clinical Epidemiology, 2025
- The Paradox of Data Sharing in Cancer Randomized Clinical Trials—A Call for Greater TransparencyJAMA Oncology, 2025
- Lifting of Embargoes to Data Sharing in Clinical Trials Published in Top Medical JournalsJAMA, 2024
- Trials and Tribulations—11 Reasons Why We Need to Promote Clinical Trials Data SharingJAMA Network Open, 2021
- Evaluation of Data Sharing After Implementation of the International Committee of Medical Journal Editors Data Sharing Statement RequirementJAMA Network Open, 2021
- Trialists’ Intent to Share Individual Participant Data as Disclosed at ClinicalTrials.govJAMA, 2018
- Use of Open Access Platforms for Clinical Trial DataJAMA, 2016
- Nonselective β‐blockers do not affect mortality in cirrhosis patients with ascites: Post Hoc analysis of three randomized controlled trials with 1198 patientsHepatology, 2016
- 12 weeks of interferon-based therapy is feasible in patients with hepatitis C-related cirrhosis and thrombocytopenia: A post hoc analysis of eltrombopag studiesDigestive and Liver Disease, 2015
- Deleterious Effects of Beta-Blockers on Survival in Patients With Cirrhosis and Refractory Ascites†,‡Hepatology, 2010